Press Releases

The Alliance for Regenerative Medicine Announces Second Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo

July 24, 2017

WASHINGTON, D.C.

The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

July 19, 2017

WASHINGTON, DC

The Alliance for Regenerative Medicine Issues Statement on U.S. FDA Oncologic Drugs Advisory Committee Meeting Regarding Novartis’ CAR-T Product Biologics License Application

July 12, 2017

The Alliance for Regenerative Medicine Announces the Appointment of Janet Lynch Lambert as Chief Executive Officer

June 27, 2017

WASHINGTON, D.C.

The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, formally announces that its Board of Directors has named Janet Lynch Lambert as the organization’s first chief executive officer. The organization informed its membership early last week of the decision.